ClinConnect ClinConnect Logo
Search / Trial NCT06822218

High Tone Power Therapy Versus Transcutanuoselectrical Nerve Stimulation on Polyneuropathic Pain in Diabetic Patients

Launched by CAIRO UNIVERSITY · Feb 11, 2025

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying two different therapies to help manage pain caused by diabetic polyneuropathy, a condition that affects the nerves due to diabetes. The two methods being compared are High Tone Power Therapy and Transcutaneous Electrical Nerve Stimulation (TENS). By understanding how these treatments work, the researchers hope to find effective, non-drug options that could help improve the quality of life for patients suffering from this type of pain.

To participate in this trial, you must be a male between the ages of 50 and 60 who has been diagnosed with diabetic polyneuropathy for over 10 years and can walk independently. The study is looking for 60 participants who are under good medical control, with specific blood sugar levels. If you have certain medical conditions, such as psychiatric disorders or issues that affect your balance, you may not qualify for this study. Participants can expect to receive one of the two therapies and will help researchers learn more about non-invasive treatments for nerve pain, which could lead to better management strategies for diabetic patients in the future.

Gender

MALE

Eligibility criteria

  • Inclusion Criteria:
  • * The patient selection will be according to the following criteria:
  • 1. Sixty male patients are diagnosed with diabetic polyneuropathy their ages will be ranged from 50-60 years old.
  • 2. All patients are ambulant independently.
  • 3. All patients are under full medical control
  • 4. HbA1c is ranged from 6.5 : 7 %.
  • 5. Patients has diabetes more than 10 years.
  • Exclusion Criteria:
  • * The participants will be excluded if they meet one of the following criteria:
  • 1. Psychiatric disorders or seizures.
  • 2. Visual and auditory impairment or tremors influencing balance.
  • 3. Other neuromuscular disorders.
  • 4. Foot deformities and ulcers.
  • 5. Lower limb operations.
  • 6. Feverish systemic infection
  • 7. cardiac pacemaker.

About Cairo University

Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.

Locations

Giza, , Egypt

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported